PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

NCT02702492 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

60

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Solid Tumors
NHL

Interventions

DRUG: KPT-9274
DRUG: Niacin ER
DRUG: Nivolumab

Sponsor

Karyopharm Therapeutics Inc